an undergraduate student at Northwestern University? a high school student thinking about where to go to college? interested and strong in mathematics and data analysis? thinking about a career — or a ...

GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3, after its cobolimab candidate flunked a phase 3 trial in lung cancer.

A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study, in ...

Oxford Professor Colin Espie joins us and our Dream Psychologist returns. A hand picked mix of Pop, Jazz, Folk, Soul and more from across the eras. Music aficionado Mike also brings us his chosen ...

Bobby brings you the best of community programming from across England. Liz puts a smile on your face with great guests, big events and all the music you love.